Candel Therapeutics, Inc. (CADL) Ownership

$5.39

$0.06 (-1.08%)
Last update: 09:57 AM EST
Day's range
$5.46
Day's range
$5.7

Candel Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/12/2025 7.09 M $40.03 M   80.58% 14.04%
BAKER BROS. ADVISORS LP 05/15/2025 2.44 M $13.77 M   -18.27% 4.83%
05/19/2025 2.15 M $12.16 M   10.96% 4.26%
BLACKROCK, INC. 05/02/2025 1.76 M $9.97 M   48.97% 3.49%
VANGUARD GROUP INC 05/09/2025 1.74 M $9.81 M   29.64% 3.44%
PORTOLAN CAPITAL MANAGEMENT, LLC 05/15/2025 881.18 K $4.98 M   16.91% 1.75%
HALTER FERGUSON FINANCIAL INC. 05/09/2025 693.15 K $3.92 M   1.73% 1.37%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 687.46 K $3.89 M   50.95% 1.36%
STATE STREET CORP 05/15/2025 563.40 K $3.18 M   0.43% 1.12%
SANDS CAPITAL VENTURES, LLC 05/14/2025 405.84 K $2.29 M   0.00% 0.80%
CITADEL ADVISORS LLC 05/15/2025 270.50 K $1.53 M   -4.11% 0.54%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 253.10 K $1.43 M   -31.63% 0.50%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 241.18 K $1.36 M   -18.09% 0.48%
NORTHERN TRUST CORP 05/13/2025 235.54 K $1.33 M   42.73% 0.47%
MARSHALL WACE, LLP 05/15/2025 234.60 K $1.33 M   100.00% 0.46%
FRANKLIN RESOURCES INC 05/13/2025 211.01 K $1.19 M   100.00% 0.42%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 209.70 K $1.18 M   -68.30% 0.42%
MILLENNIUM MANAGEMENT LLC 05/15/2025 208.61 K $1.18 M   559.61% 0.41%
BANK OF AMERICA CORP /DE/ 05/15/2025 179.25 K $1.01 M   168.30% 0.36%
HB WEALTH MANAGEMENT, LLC 05/07/2025 94.30 K $532.80 K   8.02% 0.19%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 83.88 K $473.92 K   60.72% 0.17%
05/12/2025 78.15 K $441.52 K   100.00% 0.15%
SQUAREPOINT OPS LLC 05/15/2025 75.08 K $424.19 K   288.78% 0.15%
COMMONWEALTH EQUITY SERVICES, LLC 05/09/2025 65.07 K $368.00 K   58.33% 0.13%
MORGAN STANLEY 05/15/2025 62.48 K $352.99 K   -17.00% 0.12%
BANK OF NEW YORK MELLON CORP 04/29/2025 60.76 K $343.29 K   35.08% 0.12%
BIRCHVIEW CAPITAL, LP 05/15/2025 60.00 K $339.00 K   0.00% 0.12%
GOLDMAN SACHS GROUP INC 05/16/2025 54.67 K $308.86 K   -16.20% 0.11%
MML INVESTORS SERVICES, LLC 05/14/2025 48.42 K $274.00 K   -1.66% 0.10%
CITADEL ADVISORS LLC 05/15/2025 47.90 K $270.64 K   -58.17% 0.09%
MONETA GROUP INVESTMENT ADVISORS LLC 05/15/2025 38.87 K $219.61 K   100.00% 0.08%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2025 37.71 K $213.06 K   100.00% 0.07%
RHUMBLINE ADVISERS 05/29/2025 33.30 K $188.15 K   26.76% 0.07%
BARCLAYS PLC 05/15/2025 31.32 K $177.00 K   -8.73% 0.06%
INTECH INVESTMENT MANAGEMENT LLC 05/20/2025 28.57 K $161.40 K   100.00% 0.06%
DEUTSCHE BANK AG\ 05/09/2025 26.21 K $148.09 K   -16.85% 0.05%
05/15/2025 25.05 K $141.50 K   25.23% 0.05%
STRATOS WEALTH ADVISORS, LLC 04/30/2025 23.00 K $129.95 K   100.00% 0.05%
RAYMOND JAMES FINANCIAL INC 05/13/2025 22.65 K $127.97 K   100.00% 0.04%
JANNEY MONTGOMERY SCOTT LLC 04/17/2025 21.09 K $119.00 K   104.26% 0.04%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 21.02 K $118.75 K   -3.85% 0.04%
CITIGROUP INC 05/12/2025 20.24 K $114.35 K   8.79% 0.04%
AXQ CAPITAL, LP 05/13/2025 19.94 K $112.68 K   100.00% 0.04%
ENTRYPOINT CAPITAL, LLC 05/14/2025 17.91 K $101.18 K   100.00% 0.04%
SIMPLEX TRADING, LLC 05/12/2025 17.11 K $96.00 K   274.41% 0.03%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 05/15/2025 16.75 K $94.63 K   37.67% 0.03%
METLIFE INVESTMENT MANAGEMENT, LLC 05/14/2025 15.23 K $86.03 K   10.56% 0.03%
JPMORGAN CHASE & CO 05/12/2025 14.26 K $80.59 K   36.80% 0.03%
COREBRIDGE FINANCIAL, INC. 05/14/2025 13.93 K $78.72 K   29.37% 0.03%
ADVISOR GROUP HOLDINGS, INC. 05/12/2025 13.81 K $78.00 K   51,029.63% 0.03%

Candel Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 89 institutional investors and hedge funds held shares of Candel Therapeutics, Inc.. The most heavily invested institutionals were:

FMR LLC: 7.09 M

BAKER BROS. ADVISORS LP: 2.44 M

BlackRock, Inc.: 1.76 M

VANGUARD GROUP INC: 1.74 M

Portolan Capital Management, LLC: 881,184

Halter Ferguson Financial Inc.: 693,153

41.98% of Candel Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 21.64 M shares in the last 24 months. This purchase volume represents approximately $121.83 M in transactions.